i have some model where tki inhibit bcr-... - tlooto, The Most Powerful AcademicGPT

Your model is focused on the intricate mechanisms involving the inhibition of BCR-ABL by tyrosine kinase inhibitors (TKIs), which induce ribosome collision, activate the ZAK-dependent ribotoxic stress response (RSR), and subsequently lead to p38 MAPK phosphorylation and apoptosis in chronic myeloid leukemia (CML) cells. This model builds on current understanding of CML pathology and treatment mechanisms. Key Components and Mechanisms: 1. BCR-ABL and TKIs: - The BCR-ABL fusion protein, resulting from the t(9;22)(q34;q11) translocation, is a constitutively active tyrosine kinase that plays a critical role in CML pathogenesis by promoting cell proliferation and inhibiting apoptosis[1][2]. - TKIs, such as imatinib, dasatinib, and nilotinib, target and inhibit this abnormal kinase activity, leading to reduced leukemic cell proliferation and increased apoptosis[2][3]. 2. Ribosome Collision and ZAK-Dependent RSR: - Ribosome collision occurs when translation is disrupted, leading to ribosomal